To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...

Velocity Clinical Research, an integrated research site organization, has appointed Ines Abs as its new Country Head of ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

Dr. Keith Robinson joins as Chief Medical Officer and Dr. Lonnie Brent has been appointed Senior Vice President of Medical ...

Flow Sciences, a global leader in advanced containment solutions, announced the opening of a new office in the Research ...

The new 1,200 square-meter facility in Germany expands headquarters to support growth and scale Human Platelet Lysate ...

Symbiosis Pharmaceutical Services, a global CMO, has successfully completed its 1,000th sterile drug product batch. The ...

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars ...

Evotec SE has signed a non-binding agreement with Sandoz AG regarding the potential sale of Just – Evotec Biologics EU, which ...

This acquisition strengthens Tobin Scientific's regional footprint in New England as well as its life sciences capabilities.